Inventor · disambiguated record
Rajesh Bandekar
Also filed as: BANDEKAR RAJESH
0 granted patents·11 pending applications·0 citations·filing 2020–2023
Files withJANSSEN BIOTECH INC11
Top patents by PatentIndex Score
11 records- 0168US2023348615A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their UsesJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0262US2023295333A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Pomalidomide and DexamethasoneJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0362US2023250174A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Lenalidomide and DexamethasoneJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0462US2023277660A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib, Mephalan and PrednisoneJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0562US2023330224A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib and DexamethasoneJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0660US2022041745A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their UsesJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 0754US2020308297A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their UsesJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 0852US2020316197A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib and DexamethasoneJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 0949US2020308284A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Lenalidomide and DexamethasoneJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 1049US2020330593A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib, Mephalan and PrednisoneJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 1149US2020308296A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Pomalidomide and DexamethasoneJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rajesh Bandekar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →